RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

324 hedge funds and large institutions have $9.31B invested in Royalty Pharma in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 139 increasing their positions, 106 reducing their positions, and 51 closing their positions.

Holders
324
Holders Change
-9
Holders Change %
-2.7%
% of All Funds
5.11%
Holding in Top 10
8
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-20%
% of All Funds
0.13%
New
45
Increased
139
Reduced
106
Closed
51
Calls
$21.9M
Puts
$5.29M
Net Calls
+$16.6M
Net Calls Change
-$18.1M

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$266M
2
Goldman Sachs
2
Goldman Sachs
New York
$112M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$55.5M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$34.8M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.19B

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.04B
2
Capital International Investors
2
Capital International Investors
California
$0
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$303M
4
RWJF
4
Robert Wood Johnson Foundation
New Jersey
$0
5
Renaissance Technologies
5
Renaissance Technologies
New York
$23.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$1.46B 47,429,861 +79,403 +0.2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.19B 38,847,796 +917,777 +2%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.04B 33,884,250 -6,099,866 -15%
BlackRock
4
BlackRock
New York
$638M 20,741,519 +892,677 +4%
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$569M 18,500,588 -418,162 -2%
Viking Global Investors
6
Viking Global Investors
Connecticut
$303M 9,850,932 -1,353,317 -12%
JPMorgan Chase & Co
7
JPMorgan Chase & Co
New York
$269M 8,736,171 +64,608 +0.7%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$266M 8,650,000 +1,405,133 +19%
State Street
9
State Street
Massachusetts
$252M 8,186,838 -153,967 -2%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$189M 6,145,864 +153,738 +3%
Norges Bank
11
Norges Bank
Norway
$126M 4,097,151 -270,557 -6%
Aberdeen Group
12
Aberdeen Group
United Kingdom
$119M 3,875,153 -103,262 -3%
Swedbank
13
Swedbank
Sweden
$118M 3,850,100 +795,155 +26%
Goldman Sachs
14
Goldman Sachs
New York
$112M 3,647,056 +1,343,711 +58%
SGA
15
Siguler Guff Advisers
New York
$104M 3,391,754 – –
SCM
16
Suvretta Capital Management
New York
$93.7M 3,047,049 – –
Manulife (Manufacturers Life Insurance)
17
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$76.6M 2,490,414 -288,246 -10%
Legal & General Group
18
Legal & General Group
United Kingdom
$74.2M 2,414,630 +161,230 +7%
Northern Trust
19
Northern Trust
Illinois
$73M 2,373,688 -104,040 -4%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$70.5M 2,294,416 -181,531 -7%
Janus Henderson Group
21
Janus Henderson Group
United Kingdom
$69.9M 2,274,100 -289,895 -11%
Ameriprise
22
Ameriprise
Minnesota
$67.9M 2,208,887 +723,451 +49%
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$58.8M 1,914,216 -41,909 -2%
Millennium Management
24
Millennium Management
New York
$57.6M 1,875,227 -163,655 -8%
Marshall Wace
25
Marshall Wace
United Kingdom
$55.5M 1,806,621 +1,134,091 +169%
1
2 3 4 5